We are live on ! Find out more
UL

Ulys LLC Portfolio holdings

AUM $25.4M
1-Year Est. Return 201.03%
This Fund
S&P 500
This Quarter Est. Return
-35.46%
1 Year Est. Return
+201.03%
3 Year Est. Return
-31.51%
5 Year Est. Return
-50.88%
10 Year Est. Return
AUM
$27.5M
AUM Growth
-$14.5M
Cap. Flow
+$537K
Cap. Flow %
1.95%
Top 10 Hldgs %
100%
Holding
2
New
Increased
1
Reduced
Closed

Top Buys

Rank Stock Value
1
LXRX icon
Lexicon Pharmaceuticals
LXRX
+$537K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LXRX icon
1
Lexicon Pharmaceuticals
LXRX
$1.03B
$27.5M 99.97%
4,321,215
+66,557
+2% +$537K
CERE
2
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$7K 0.03%
3,891

Similar funds

Ulys LLC's Q4 2014 Portfolio in Review

As of Q4 2014, Ulys LLC held 2 positions worth $27.5M, down 34% from $42M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2014: portfolio turnover was 0%. Ulys LLC opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier.

  • Ulys LLC added most to Lexicon Pharmaceuticals in Q4 2014, an estimated $537K increase.
  • Ulys LLC's ten largest holdings make up 100% of its $27.5M portfolio in Q4 2014.
  • Ulys LLC opened 0 new positions and closed 0 in Q4 2014.
  • Ulys LLC's portfolio value fell 34% quarter-over-quarter to $27.5M.

Based on Ulys LLC's 13F filing for Q4 2014, filed 12 Feb 2015.